Wholesome High Stability Probiotics Granule Lactobacillus Rhamnosus

• Customization: Available
• CAS No.: N
• Formula: N
• Model NO.: LR05
• EINECS: N
• Resource: Natural
• Smell: Addable
• Appearance: Dry Varying Sizes of Granule
• Identification: 16s Rrna
• Net Content: Multiple(1, 2, 5, 10, 25kg)
• Density Cfu: 100b /G
• Transport Package: Plastic
• Specification: TBC
• Trademark: BIODEP
• Origin: China
• HS Code: 21069090
• Production Capacity: 3, 000kg/M

Product Description

     Introduction
Lactobacillus rhamnosus has been found in many niches, including human intestine, vagina, mouth and dairy products. To intensively investigate the genomic diversity of this species, draft genomes of 70 L. rhamnosus strains isolated from different subjects were sequenced and further investigated. The pan-genome of L. rhamnosus was open. And gene-trait matching (GTM) was done to explore the carbohydrate utilization ability and antibiotic resistance, and to establish a pattern of gene existence/absence and growth/absence. There were no significant correlations between genetic diversity of the strains and the age or region of the donors. The current results extend the understanding of L. rhamnosus, which could be used as a reference for subsequent research as well as mining and application of the species.


    L. rhamnosus is a Gram-positive bacterium that exists in a variety of niches, such as the human intestine and vagina (Pascual et al., 2008). L. rhamnosus GG is one of the best commercialized strain among L. rhamnosus. It has a strong resistance to gastrointestinal digestion and potential probiotic characteristics. Previous studies on L. rhamnosus focused on its functional benefits including various diarrhea treatments, immunity improvement, and respiratory infections prevention (Barbieri et al., 2017; Evans et al., 2016). Phenotype studies were carried out, such as acid tolerance, bile salt tolerance, carbohydrate utilization and adherence to epithelial cells (Ceapa et al., 2016, 2015; Succi et al., 2005; Tripathi et al., 2013).

Dosing
For general use as a dietary supplement
Dose: 1 capsule per day

Concurrently with antibiotics
Dose: 1 capsule twice a day throughout antibiotic therapy and for one week after antibiotic therapy

Traveling
Dose: 1 capsule twice daily throughout the trip
It is best to start 2 to 3 days prior to travel.

Usual Pediatric Dose for Dietary Supplement

Dose: One-half to one capsule per day.
Open the capsule and stir the contents into a cool drink or mix into baby food or applesauce.

Storage
be sealed and stored in a dry place to prevent moisture deterioration.
More;

Probiotics	Strain Number	Type(CFU/g)
Lactiplantibacillus plantarum	Lp3a	5-500B
Lacticaseibacillus rhamnosus	LR05	5-400B
Lacticaseibacillus casei	LC11	5-400B
Lacticaseibacillus paracasei	LPC45	5-400B
Lactobacillus fermentum	LF021	5-300B
Lactobacillus salivarius	LS01	5-100B
Lactobacillus reuteri	LR06	5-200B
Lactobacillus acidophius	LA16	5-200B
Lactobacillus  helveticus	LH030/LZ-R-5	5-200B
Lactobacillus crispatus	LCP051	5-100B
Lactobacillus gasseri	LG021/LG019	5-200B
Lactobacillus johnsonii	LJ10	5-100B
Lactobacillus delbrueckii subsp. bulgaricus	LB45	5-20B
Bifidobacterium animalis subsp. lactis	Bla019	5-400B
Bifidobacterium animalis subsp. animalis	BA023	5-500B
Bifidobacterium breve	BB033	5-200B
Bifidobacterium longum subsp. longum	BL5b	5-100B
Bidobacterium longum subsp. infantis	BI08	5-50B
Bifidobacterium bifidum	BMC31	5-200B
Bifidobacterium adolesentis	BAA021	5-100B
Streptococcus salivarius subsp. thermophilus	ST076	5-300B
Pediococcus pentosaceus	PP016	5-300B
Pediococcus acidolactici	PAL31	5-400B
Leuconostoc mesenteroides subsp. mesenteroides	LCM020	5-200B
Weizmannia  coagulans	BC01	5-100B
Akkermansia  muciniphila	AMP018	5-200B